HTMC0435 / Shanghai Huilun - LARVOL DELTA

A phase Ib/II study of HTMC0435 plus dose-reduced etoposide and platinum in previously untreated extensive-stage small-cell lung cancer (ES-SCLC) (ESMO 2025) - P1/2 | "Pts were administered with HTMC0435 (8 mg or 12 mg twice daily on days 1-21) in combination with etoposide (75 mg/m 2 on days 1-3) and cisplatin (20 mg/m 2 on days 1-3) or carboplatin (AUC 4 on day 1), every 21 days as one cycle. No treatment discontinuations and no deaths occurred due to TRAEs. Conclusions This combination of HTMC0435 plus dose-reduced etoposide and platinum showed promising anti-tumor activity and manageable safety in previously untreated ES-SCLC patients."

P1/2 data • Lung Cancer • Oncology • Small Cell Lung Cancer • Solid Tumor

A dose exploration and dose expansion phase Ib/II study to evaluate oral HTMC0435 tablets in combination with platinum and etoposide in patients with extensive stage small cell lung cancer (ChiCTR) - P1/2 | N=74 | Recruiting | Sponsor: The First Affiliated Hospital of Zhengzhou University; Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.

New P1/2 trial • Lung Cancer • Oncology • Small Cell Lung Cancer • Solid Tumor

Efficacy and safety of HTMC0435 combination with temozolomide in relapsed extensive-stage small-cell lung cancer (ES-SCLC): A phase Ib/II study. (ASCO 2025) - P1b/2 | "This combination of HTMC0435 and TMZ showed promising anti-tumor activity and manageable safety both in platinum-sensitive and platinum-resistant SCLC patients. Clinical trial information: NCT05728619. Research Sponsor: Shanghai Yidian Pharma."

Clinical • P1/2 data • Anemia • Leukopenia • Lung Cancer • Neutropenia • Oncology • Small Cell Lung Cancer • Solid Tumor • Thrombocytopenia

HTMC0435 and Temozolomide in Treating Patients With Small Cell Lung Cancer (clinicaltrials.gov) - P1b/2 | N=64 | Recruiting | Sponsor: Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. | Not yet recruiting ➔ Recruiting

Enrollment open • Lung Cancer • Neuroendocrine Tumor • Oncology • Small Cell Lung Cancer • Solid Tumor